Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs3758745 | chr11:33059513 | C/T | 1.09E-6 | 293 | 21.97 | 24.77 | 1.7 | KM Plot |
CESC | rs3767590 | chr1:112299911 | A/G | 0 | 298 | 21.33 | 20.47 | 4.07 | KM Plot |
CESC | rs3774780 | chr3:129224106 | T/G | 4.83E-5 | 295 | 21.73 | 20.63 | 14.73 | KM Plot |
CESC | rs3783838 | chr14:90733012 | A/G | 5.44E-5 | 299 | 20.23 | 21.3 | 24.62 | KM Plot |
CESC | rs3785100 | chr16:67997920 | T/C | 2.37E-5 | 288 | 20.63 | 29.57 | 16.4 | KM Plot |
CESC | rs379909 | chr19:11383810 | A/G | 2.72E-5 | 290 | 24.47 | 21.1 | 21.2 | KM Plot |
CESC | rs3809630 | chr16:67879400 | G/A | 2.75E-6 | 294 | 20.92 | 28.47 | 17.43 | KM Plot |
CESC | rs3812062 | chr5:126112283 | C/A | 0 | 291 | 21.2 | 20.77 | 1.73 | KM Plot |
CESC | rs3814964 | chr11:2999507 | G/T | 2.81E-5 | 294 | 21.2 | 24.3 | 21.43 | KM Plot |
CESC | rs3863952 | chr7:123171842 | A/G | 6.3E-13 | 292 | 23.42 | 18.07 | 3.97 | KM Plot |
CESC | rs390313 | chr19:11392004 | T/C | 5.37E-5 | 293 | 20.23 | 21.27 | 21.2 | KM Plot |
CESC | rs3933766 | chr13:20110195 | C/T | 3.98E-5 | 299 | 14.9 | 26.35 | 21.12 | KM Plot |
CESC | rs401511 | chr19:11386386 | A/G | 2.21E-5 | 292 | 20.23 | 22.28 | 21.2 | KM Plot |
CESC | rs4030739 | chr10:88227575 | T/A | 1.6E-14 | 297 | 3.33 | 24.6 | 21.17 | KM Plot |
CESC | rs412298 | chr19:11391347 | A/G | 3.87E-5 | 293 | 23.33 | 23.3 | 21.2 | KM Plot |